MedTrace Logo

Determination of Perioperative Acute Kidney Injury Incidence

NCT02521350 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2015-08-13

No results posted yet for this study

Summary

In the last few years, acute renal injury (AKI) definition has been significantly changed. In the light of the data obtained from multicenter international studies, acute renal injury was redefined according to RIFLE, AKIN and KDIGO criteria. The common criteria of all three criteria in acute renal failure is the increment of level of creatinine as 0.3 mg/dL or 50 % increment of respective basal value of serum creatinine.

In the current study, older than 40 years patients with no specific gender, who will stay at least one night in hospital will be included and cardiovascular and urological surgery patients and patients with known renal insufficiency will be excluded. It was aimed to measure serum creatinine levels in all included patients at baseline and up to 24h after surgery and will be determined acute kidney injury incidence and risk factors according to new criteria.

Conditions

  • Intensive Care Unit Syndrome

Sponsors & Collaborators

  • Kadikoy Hospital

    collaborator OTHER

  • Acibadem Atakent University Hospital

    collaborator OTHER

  • Acibadem Fulya Hospital

    collaborator OTHER

  • Acibadem Ankara Hospital

    collaborator OTHER

  • Acibadem Eskişehir Hastanesi

    collaborator OTHER

  • Acibadem Bursa Hospital

    collaborator OTHER

  • Kayseri Acibadem Hospital

    collaborator UNKNOWN

  • Acıbadem Adana Hospital

    collaborator OTHER

  • Acibadem Kozyatagi Hospital

    collaborator OTHER

  • Acibadem Kocaeli Hospital

    collaborator OTHER

  • Acibadem University

    lead OTHER

Principal Investigators

  • Fevzi TORAMAN, Prof.Dr. · Acibadem University

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02521350 on ClinicalTrials.gov